FeesSafety
Pluang+

Bioventus to release Q3 fiscal 2026 results on Nov 2 with a conference call.

Company Fundamentals
27 Oct 2026, 14:00 WIB
GlobeNewsWire
View Source
Neutral
Bioventus to release Q3 fiscal 2026 results on Nov 2 with a conference call.

Bioventus, a leader in active healing innovations, will report its third quarter fiscal year 2026 financial results on November 2, 2026, after market close. The company will hold a conference call at 4:30 p.m. Eastern Time to discuss the results and provide a business update. Investors can access the call via phone or live webcast on Bioventus' investor relations website. This update follows their recent Q2 report showing revenue growth and earnings improvements.

Bioventus is set to report its third quarter fiscal year 2026 financial results on November 2, 2026. For readers following the health sector, here is Pluang's market snapshot as of Oct 27, 2026 17:43 WIB: out of 150 priced health-sector US stocks tradable on Pluang, 69 rose and 68 fell today. Notable movers include NUWE (Nuwellis Inc) at USD 3.21 with a 1-day change of +4.90% and Pluang order activity showing 94% Sell / 6% Buy, AMWL (American Well Corp) at USD 14.20 up +4.87%, and MRVI (Maravai LifeSciences Holdings Inc. Class A Common Stock) at USD 7.22 down -4.75%.

More News

Man Group discloses 5.64% stake in Vesuvius plc amid offer involving RHI Magnestia N.V.

Man Group discloses 5.64% stake in Vesuvius plc amid offer involving RHI Magnestia N.V.

Man Group PLC has publicly disclosed holding a 5.64% interest in Vesuvius plc, including direct shares and cash-settled derivatives. This disclosure is related to an ongoing offer involving RHI Magnestia N.V., which is also named in the filing. The d...

Neutral
43 minutes ago
Defense contractors must review CUI access before licensing Microsoft 365 Copilot in GCC High cloud.

Defense contractors must review CUI access before licensing Microsoft 365 Copilot in GCC High cloud.

eSoftware Associates advises defense contractors to carefully map controlled unclassified information (CUI) access permissions before licensing Microsoft 365 Copilot in the GCC High cloud environment. Moving to GCC High does not automatically grant c...

Market News
Neutral
43 minutes ago
Nautilus reports Q3 2026 results with $0.2M revenue, $15.6M net loss, and advances in proteome analysis tech.

Nautilus reports Q3 2026 results with $0.2M revenue, $15.6M net loss, and advances in proteome analysis tech.

Nautilus Biotechnology announced its Q3 2026 financial results, reporting $0.2 million in revenue mainly from grants and early access services, and a net loss of $15.6 million. The company highlighted progress in its proteome analysis platform, inclu...

Company Fundamentals
Bullish
1 hour ago
Eviden launches ASTRA-LAS, a new AI-powered tactical decision-support tool for naval operations.

Eviden launches ASTRA-LAS, a new AI-powered tactical decision-support tool for naval operations.

Eviden, part of Atos Group, has introduced ASTRA-LAS, a tactical decision-support solution designed to aid naval officers in complex maritime environments. The system uses operational data and AI to enhance situational awareness, reduce cognitive loa...

Others
Bullish
2 hours ago
Eviden launches ASTRA-LAS, a tactical aid system enhancing naval decision-making with AI and real-time data.

Eviden launches ASTRA-LAS, a tactical aid system enhancing naval decision-making with AI and real-time data.

Eviden, part of Atos Group, has introduced ASTRA-LAS, a new AI-powered tactical assistant designed to support naval operations by providing enhanced visualizations, automated analyses, and mission-specific recommendations. This system helps naval off...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App